Anti-CBL / Casitas B-lineage lymphoma proto-oncogene

Anti-CBL / Casitas B-lineage lymphoma proto-oncogene
Artikelnummer Größe Datenblatt Manual SDB Lieferzeit Menge Preis
NSJ-R30898 100 µg - -

3 - 10 Werktage*

755,00 €
 
0.5mg/ml if reconstituted with 0.2ml sterile DI water. Casitas B lineage lymphoma proto oncogene... mehr
Produktinformationen "Anti-CBL / Casitas B-lineage lymphoma proto-oncogene"
0.5mg/ml if reconstituted with 0.2ml sterile DI water. Casitas B lineage lymphoma proto oncogene is also known as CBL, RNF55, and E3 ubiquitin protein ligase. Wei et al.(1990) mapped the CBL gene to chromosome 11q23.3-qter by molecular characterization of the breakpoints in 2 somatic cell hybrids. The encoded protein is one of the enzymes required for targeting substrates for degradation by the proteasome. This protein mediates the transfer of ubiquitin from ubiquitin conjugating enzymes(E2) to specific substrates. This protein also contains an N-terminal phosphotyrosine binding domain that allows it to interact with numerous tyrosine-phosphorylated substrates and target them for proteasome degradation. As such it functions as a negative regulator of many signal transduction pathways. This gene has been found to be mutated or translocated in many cancers including acute myeloid leukaemia. Mutations in this gene are also the cause of Noonan syndrome-like disorder. Protein function: Adapter protein that functions as a negative regulator of many signaling pathways that are triggered by activation of cell surface receptors. Acts as an E3 ubiquitin-protein ligase, which accepts ubiquitin from specific E2 ubiquitin-conjugating enzymes, and then transfers it to substrates promoting their degradation by the proteasome (PubMed:17094949). Ubiquitinates SPRY2 (PubMed:17094949, PubMed:17974561). Ubiquitinates EGFR (PubMed:17974561). Recognizes activated receptor tyrosine kinases, including KIT, FLT1, FGFR1, FGFR2, PDGFRA, PDGFRB, CSF1R, EPHA8 and KDR and terminates signaling. Recognizes membrane-bound HCK, SRC and other kinases of the SRC family and mediates their ubiquitination and degradation. Participates in signal transduction in hematopoietic cells. Plays an important role in the regulation of osteoblast differentiation and apoptosis. Essential for osteoclastic bone resorption. The 'Tyr-731' phosphorylated form induces the activation and recruitment of phosphatidylinositol 3-kinase to the cell membrane in a signaling pathway that is critical for osteoclast function. May be functionally coupled with the E2 ubiquitin- protein ligase UB2D3. In association with CBLB, required for proper feedback inhibition of ciliary platelet-derived growth factor receptor- alpha (PDGFRA) signaling pathway via ubiquitination and internalization of PDGFRA. [The UniProt Consortium]
Schlagworte: Anti-CBL, Anti-CBL2, Anti-Proto-oncogene c-Cbl, Anti-RING finger protein 55, Anti-Signal transduction protein CBL, Anti-E3 ubiquitin-protein ligase CBL, Anti-RING-type E3 ubiquitin transferase CBL, Anti-Casitas B-lineage lymphoma proto-oncogene, CBL Antib
Hersteller: NSJ Bioreagents
Hersteller-Nr: R30898

Eigenschaften

Anwendung: WB
Antikörper-Typ: Polyclonal
Konjugat: No
Wirt: Rabbit
Spezies-Reaktivität: human, mouse, rat
Immunogen: An amino acid sequence from the C-terminus of human CBL (NLMSQGYSYQDIQKA)
Format: Purified

Handhabung & Sicherheit

Lagerung: +4°C
Versand: +4°C (International: +4°C)
Achtung
Nur für Forschungszwecke und Laboruntersuchungen: Nicht für die Anwendung im oder am Menschen!
Hier kriegen Sie ein Zertifikat
oder , um Analysenzertifikate anzufordern.
Bewertungen lesen, schreiben und diskutieren... mehr
Kundenbewertungen für "Anti-CBL / Casitas B-lineage lymphoma proto-oncogene"
Bewertung schreiben
oder , um eine Produktbewertung abzugeben.
Zuletzt angesehen